Work

Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research

Year: 2016

Type: article

Abstract: Blockade of the PD-1 axis has emerged as an effective anticancer immunotherapy against various tumor types. Diverse studies have identified biomarkers associated with response to these therapies. However, the clinical use of such tests is limited by their variable performance and restricted understanding of their biologic significance. Clin Cancer Res; 22(9); 2102-4. ©2016 AACRSee related article by Ock et al., p. 2261.

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-16-0169

Authors: Kurt A. Schalper, Edward Kaftan, Roy S. Herbst

Institutions: Yale Cancer Center, Yale University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Cancer Society, Lung Cancer Research Foundation, Yale SPORE in Lung Cancer, National Cancer Institute